| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ADCY10 | CNR1 | ENSOARP00000013180 | ENSOARP00000021470 | Adenylate cyclase 10. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.906 |
| ADCY10 | ENTPD2 | ENSOARP00000013180 | ENSOARP00000000284 | Adenylate cyclase 10. | Ectonucleoside triphosphate diphosphohydrolase 2; Belongs to the GDA1/CD39 NTPase family. | 0.900 |
| ADCY10 | GCH1 | ENSOARP00000013180 | ENSOARP00000022652 | Adenylate cyclase 10. | GTP cyclohydrolase 1. | 0.800 |
| ADCY10 | GNAI1 | ENSOARP00000013180 | ENSOARP00000018654 | Adenylate cyclase 10. | G protein subunit alpha i1. | 0.727 |
| ADCY10 | GNAI2 | ENSOARP00000013180 | ENSOARP00000010904 | Adenylate cyclase 10. | Uncharacterized protein. | 0.727 |
| ADCY10 | GNAS | ENSOARP00000013180 | ENSOARP00000017791 | Adenylate cyclase 10. | GNAS complex locus. | 0.776 |
| ADCY10 | LOC101108001 | ENSOARP00000013180 | ENSOARP00000001255 | Adenylate cyclase 10. | Guanylate cyclase domain-containing protein. | 0.906 |
| ADCY10 | MOCS1 | ENSOARP00000013180 | ENSOARP00000000484 | Adenylate cyclase 10. | Molybdenum cofactor synthesis 1. | 0.800 |
| ADCY10 | NTPCR | ENSOARP00000013180 | ENSOARP00000003562 | Adenylate cyclase 10. | Nucleoside-triphosphatase, cancer-related. | 0.900 |
| ADCY10 | NUDT2 | ENSOARP00000013180 | ENSOARP00000009971 | Adenylate cyclase 10. | Nudix hydrolase 2; Belongs to the Nudix hydrolase family. | 0.901 |
| CNR1 | ADCY10 | ENSOARP00000021470 | ENSOARP00000013180 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Adenylate cyclase 10. | 0.906 |
| CNR1 | GNAI1 | ENSOARP00000021470 | ENSOARP00000018654 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit alpha i1. | 0.938 |
| CNR1 | GNAI2 | ENSOARP00000021470 | ENSOARP00000010904 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Uncharacterized protein. | 0.940 |
| CNR1 | LOC101108001 | ENSOARP00000021470 | ENSOARP00000001255 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Guanylate cyclase domain-containing protein. | 0.906 |
| ENTPD2 | ADCY10 | ENSOARP00000000284 | ENSOARP00000013180 | Ectonucleoside triphosphate diphosphohydrolase 2; Belongs to the GDA1/CD39 NTPase family. | Adenylate cyclase 10. | 0.900 |
| ENTPD2 | LOC101108001 | ENSOARP00000000284 | ENSOARP00000001255 | Ectonucleoside triphosphate diphosphohydrolase 2; Belongs to the GDA1/CD39 NTPase family. | Guanylate cyclase domain-containing protein. | 0.900 |
| ENTPD2 | NTPCR | ENSOARP00000000284 | ENSOARP00000003562 | Ectonucleoside triphosphate diphosphohydrolase 2; Belongs to the GDA1/CD39 NTPase family. | Nucleoside-triphosphatase, cancer-related. | 0.932 |
| GCH1 | ADCY10 | ENSOARP00000022652 | ENSOARP00000013180 | GTP cyclohydrolase 1. | Adenylate cyclase 10. | 0.800 |
| GCH1 | LOC101108001 | ENSOARP00000022652 | ENSOARP00000001255 | GTP cyclohydrolase 1. | Guanylate cyclase domain-containing protein. | 0.800 |
| GCH1 | MOCS1 | ENSOARP00000022652 | ENSOARP00000000484 | GTP cyclohydrolase 1. | Molybdenum cofactor synthesis 1. | 0.932 |